Cargando…

Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease

BACKGROUND: Epstein–Barr virus-positive post-transplant lymphoproliferative disease (PTLD) is a potentially lethal complication of iatrogenic immunosupression after transplantation. Predicting the development of PTLD allowing early and effective intervention is therefore of importance. Polymorphisms...

Descripción completa

Detalles Bibliográficos
Autores principales:	McAulay, K A, Haque, T, Crawford, D H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743368/ https://www.ncbi.nlm.nih.gov/pubmed/19738620 http://dx.doi.org/10.1038/sj.bjc.6605278

Ejemplares similares

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation
por: Marsh, H P, et al.
Publicado: (2003)

Tumour-necrosis factor-A polymorphisms and gastric cancer risk: a meta-analysis
por: Gorouhi, F, et al.
Publicado: (2008)

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

Polymorphic post-transplant lymphoproliferative disorder in a gilt
por: Tura, Giorgia, et al.
Publicado: (2019)

Association of apolipoprotein E polymorphisms and dietary factors in colorectal cancer
por: Mrkonjic, M, et al.
Publicado: (2009)

Evolutionary game theory of growth factor production: implications for tumour heterogeneity and resistance to therapies
por: Archetti, M
Publicado: (2013)

Telomere length and genetics are independent colorectal tumour risk factors in an evaluation of biomarkers in normal bowel
por: Fernandez-Rozadilla, Ceres, et al.
Publicado: (2018)

Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours
por: von Bueren, A O, et al.
Publicado: (2012)

Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue
por: Bounacer, A, et al.
Publicado: (2002)

Intra-tumour genetic heterogeneity and poor chemoradiotherapy response in cervical cancer
por: Cooke, S L, et al.
Publicado: (2011)

Anti-angiogenic action of hyperthermia by suppressing gene expression and production of tumour-derived vascular endothelial growth factor in vivo and in vitro
por: Sawaji, Y, et al.
Publicado: (2002)

Post-transplant lymphoproliferative disease
por: Dharnidharka, Vikas R., et al.
Publicado: (2009)

Interaction between polymorphisms in cell-cycle genes and environmental factors in regulating cholinesterase activity in people with exposure to omethoate
por: Duan, Xiaoran, et al.
Publicado: (2018)

Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers
por: Abend, M, et al.
Publicado: (2013)

BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface
por: Lee, A J, et al.
Publicado: (2014)

MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression
por: Presneau, N, et al.
Publicado: (2013)

Target gene selectivity of hypoxia-inducible factor-α in renal cancer cells is conveyed by post-DNA-binding mechanisms
por: Lau, K W, et al.
Publicado: (2007)

Lack of mutations within ST7 gene in tumour-derived cell lines and primary epithelial tumours
por: Brown, V L, et al.
Publicado: (2002)

Ocular post-transplant lymphoproliferative disorder
por: Chen, Yun-Wen, et al.
Publicado: (2015)

Post-transplant lymphoproliferative disease of the larynx
por: Vandjelovic, Nathan D, et al.
Publicado: (2019)

Management of post-transplant lymphoproliferative disorders
por: Dierickx, Daan, et al.
Publicado: (2019)

Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening
por: Nghiem, V T, et al.
Publicado: (2015)

Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-α-based isolated hepatic perfusion
por: van Etten, B, et al.
Publicado: (2003)

An atlas of the binding specificities of transcription factors in Pseudomonas aeruginosa directs prediction of novel regulators in virulence
por: Wang, Tingting, et al.
Publicado: (2021)

Gene expression profiling of human ovarian tumours
por: Biade, S, et al.
Publicado: (2006)

Identification of novel neuroendocrine-specific tumour genes
por: Hofsli, E, et al.
Publicado: (2008)

Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours
por: Reiman, A, et al.
Publicado: (2011)

Tumor Necrosis Factor Sustains the Generalized Lymphoproliferative Disorder ( gld ) Phenotype
por: Körner, Heinrich, et al.
Publicado: (2000)

Promoter hypermethylation of MGMT, CDH1, RAR-β and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin
por: Dhillon, V S, et al.
Publicado: (2004)

Methylation analysis of the glypican 3 gene in embryonal tumours
por: Boily, G, et al.
Publicado: (2004)

Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
por: Asleh, Rabea, et al.
Publicado: (2022)

The genetic basis of swine inflammation and necrosis syndrome and its genetic association with post-weaning skin damage and production traits
por: Leite, Natália Galoro, et al.
Publicado: (2023)

Somatic glypican 3 (GPC3) mutations in Wilms' tumour
por: White, G R M, et al.
Publicado: (2002)

Somatic mutations of KIT in familial testicular germ cell tumours
por: Rapley, E A, et al.
Publicado: (2004)

Familial risks in nervous system tumours: joint Nordic study
por: Hemminki, K, et al.
Publicado: (2010)

DICER1 hotspot mutations in non-epithelial gonadal tumours
por: Witkowski, L, et al.
Publicado: (2013)

Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer
por: Dopeso, Higinio, et al.
Publicado: (2018)

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer
por: Stoehlmacher, J, et al.
Publicado: (2004)

Differential disruption of cell cycle pathways in small cell and non-small cell lung cancer
por: Coe, B P, et al.
Publicado: (2006)

Tumour necrosis factor gene polymorphisms and migraine in Greek children
por: Pappa, Styliani, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_mtiinblogqir8o1e4g3m05vbre